Michael W. Rogers

Insider Reports History

Entity
Individual
Location
C/O Keryx Biopharmaceuticals Inc, One Marina Park Drive, Boston, MA
Signature
/s / Carolyn Rucci, attorney-in-fact for Michael W. Rogers
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael W. Rogers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. Director Common Stock 126K $159K $1.26 Jun 6, 2024 Direct
Aravive, Inc. Director Stock Option (Right to Buy) 97.1K Sep 23, 2022 Direct
Akebia Therapeutics, Inc. Director Stock Option (Right to buy) 45K Jun 6, 2024 Direct

Insider Reports Filed by Michael W. Rogers

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKBA Akebia Therapeutics, Inc. Jun 6, 2024 2 $0 4 Jun 10, 2024 Director
AKBA Akebia Therapeutics, Inc. Jun 6, 2023 2 $0 4 Jun 8, 2023 Director
ARAV Aravive, Inc. Sep 23, 2022 1 $0 4 Sep 26, 2022 Director
AKBA Akebia Therapeutics, Inc. Jun 8, 2022 2 $0 4 Jun 9, 2022 Director
ARAV Aravive, Inc. Sep 10, 2021 1 $0 4 Sep 13, 2021 Director
AKBA Akebia Therapeutics, Inc. Jun 2, 2021 2 $0 4 Jun 3, 2021 Director